Clinical Trial Update: LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LND101 in fecal microbiota transplantation combined with immune checkpoint blockade for advanced melanoma is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• LND101

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Melanoma | Phase 2 | Status: RECRUITING